A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

ClinicalTrials.gov ID: NCT06876649

Public ClinicalTrials.gov record NCT06876649. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Master Protocol to Evaluate the Long-Term Safety of Pirtobrutinib

Study identification

NCT ID: NCT06876649
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 4
Lead sponsor: Eli Lilly and Company; Industry
Enrollment: 787 participants

Conditions and interventions

Conditions

Interventions

Pirtobrutinib Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 19, 2025
Primary completion: Apr 30, 2030
Completion: Nov 30, 2032
Last update posted: Mar 1, 2026

2025 – 2032

United States locations

U.S. sites: 18
U.S. states: 14
U.S. cities: 18

Facility	City	State	ZIP	Site status
Cancer Specialists, LLC	Jacksonville	Florida	32256	Not yet recruiting
Sylvester Comprehensive Cancer Center	Miami	Florida	33136-1002	Recruiting
Florida Cancer Specialists	Sarasota	Florida	34232-6422	Recruiting
The Emory Clinic	Atlanta	Georgia	30322-1013	Not yet recruiting
Northwestern University	Chicago	Illinois	60611-3013	Not yet recruiting
Dana-Farber Cancer Institute	Boston	Massachusetts	02215	Recruiting
Mayo Clinic- Minnesota	Rochester	Minnesota	55905	Recruiting
University Of Nebraska Medical Center	Omaha	Nebraska	69198	Recruiting
Cayuga Cancer Center	Ithaca	New York	14850	Recruiting
Northwell Health	Lake Success	New York	11042-1118	Recruiting
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York	New York	New York	10065-6007	Not yet recruiting
Duke University Medical Center	Durham	North Carolina	27710-4000	Recruiting
Ohio State University Comprehensive Cancer Center	Columbus	Ohio	43210-1063	Recruiting
University of Pennsylvania Hospital	Philadelphia	Pennsylvania	19104	Recruiting
Tennessee Oncology	Nashville	Tennessee	37203-2659	Recruiting
University of Texas MD Anderson Cancer Center	Houston	Texas	77030	Recruiting
Swedish Cancer Institute	Seattle	Washington	98104-3588	Recruiting
Medical College of Wisconsin	Milwaukee	Wisconsin	53226-3548	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06876649, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 1, 2026 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06876649 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →